glp-1 prescriptions q1 2025 Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline GLP-1 Trends: Access & Shortages,

The platform focuses mainly on: Weight loss treatment using GLP-1 medications (semaglutide and tirzepatide) Hair loss treatment Skincare General wellness support Most people searching for Mochi Health are specifically interested in its tirzepatide and semaglutide programs , since thats where the company built its reputation and its customer base

55,60 Compared to semaglutide and dulaglutide, tirzepatide has demonstrated superior reduction in glycated hemoglobin (HbA1c) and body weight

Weight loss benefits: Obesity impairs sperm production and quality

In 2025, 13% of covered workers have a copayment and 67% have a coinsurance rate for outpatient surgery